Nexa Resources Announces Sale of Otavi Project
Newsfile· 2025-05-15 20:48
Nexa Resources Announces Sale of Otavi ProjectMay 15, 2025 4:48 PM EDT | Source: Nexa ResourcesLuxembourg, Luxembourg--(Newsfile Corp. - May 15, 2025) - Nexa Resources S.A. (NYSE: NEXA) ("Nexa Resources", "Nexa" or the "Company") announces today the signing of a definitive agreement between its subsidiary, Votorantim Metals Namibia (Pty) Ltd., and Midnab Resources (Pty) Ltd. ("Midnab"), a subsidiary of Midas Minerals Ltd. (ASX Symbol: MM1), for the sale of ten Exclusive Prospecting Licenses (" ...
Trust Stamp files its 2025 Q1 10-Q and provides forward-looking estimates
GlobeNewswire· 2025-05-15 20:48
Trust Stamp announced that it filed its 2025 Q1 10-Q after the Nasdaq market closed on May 15th, 2025, and gave estimated guidance for 2025, together with announcing strong growth in customer enrollment on its SaaS Orchestration LayerAtlanta, GA, May 15, 2025 (GLOBE NEWSWIRE) -- Trust Stamp announced that: It filed its Q1 10-Q report for the three months ended 31 March 2025 after the Nasdaq market closed on May 15th, 2025. Q1 2025 recognized revenue was $545 thousand, decreased from $574 thousand for Q1 of ...
Maui Land & Pineapple Company, Inc. Reports Fiscal First Quarter 2025 Results and Announces New Scalable Agri-Business Venture
GlobeNewswire· 2025-05-15 20:48
KAPALUA, Hawaii, May 15, 2025 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended March 31, 2025. The Company also announced a new agriculture-based business venture designed to maximize the value of currently underutilized croplands and stimulate economic revitalization on Maui. Additional updates from the Company will be shared at its Annual Meeting of Stockholders, which will be held virtually on Wednesday, May 21, 2025, at 8:30 ...
Shuttle Pharma Provides Corporate Update
GlobeNewswire· 2025-05-15 20:45
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update. Shuttle Pharma’s recent highlights: Phase 2 clinical trial of Ropidoxuridine for treatment of patients with glioblastoma highlights include: Patient enrollment nears milestone as n ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Iovance Biotherapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of July 14, 2025
GlobeNewswire News Room· 2025-05-15 20:41
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) between August 8, 2024, to May 8, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Karthik Trichur Sundaram v. Iovance Biotherapeutics, Inc., et al. (Case No. 3:25-cv-04177) has been commenced in the United States Dist ...
Anywhere to Participate in the KBW Virtual Real Estate Finance & Technology Conference
Prnewswire· 2025-05-15 20:37
MADISON, N.J., May 15, 2025 /PRNewswire/ -- Anywhere Real Estate Inc. (NYSE: HOUS), a global leader in residential real estate services, today announced that Chief Executive Officer and President Ryan Schneider will participate in the KBW Virtual Real Estate Finance & Technology Conference on Tuesday, May 20, 2025.'Evolving Resi Markets: A Conversation with Anywhere Real Estate', featuring Ryan Schneider, is scheduled for Tuesday, May 20, 2025 at 12:00 p.m. EST. The remarks will be webcast, with access inst ...
QuoteMedia Announces Financial Results for Q1 2025
GlobeNewswire· 2025-05-15 20:37
PHOENIX, May 15, 2025 (GLOBE NEWSWIRE) -- QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended March 31, 2025. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other ...
GTA VI Delay Looms Over Take-Two Earnings: Sales Beat, EPS Miss, Outlook Updated
Benzinga· 2025-05-15 20:36
Video game company Take-Two Interactive TTWO reported fourth-quarter financial results after market close Thursday.Here are the key highlights.What Happened: Take-Two announced fourth-quarter net bookings of $1.58 billion, up 17% year-over-year. The total beat a Street consensus estimate of $1.55 billion according to data from Benzinga Pro.The company reported adjusted earnings pre share or $1.08 for the quarter, missing a Street consensus estimate of $1.10 per share.Net bookings from recurrent consumer spe ...
Beam Global Announces First Quarter 2025 Operating Results
GlobeNewswire· 2025-05-15 20:33
SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced its first quarter results for the period ended March 31, 2025. Q1 2025 Financial Highlights Revenue CAGR 60% for trailing 60 monthsCommercial Revenues increased 41% over Q1 2024Positive GAAP Gross Margin 8%Adjusted non-GAAP Gross Margin, net of non-cash costs 21%Net ca ...
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
GlobeNewswire· 2025-05-15 20:32
$3 Million Lead Order from Strategic Investors Supports Bold TransformationVANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces a strategic financing of approximately $4 million (the “Offering”) consisting of concurrent private placements of (i) convertible debenture units (“De ...